236 results
8-K
EX-10.1
40kspwsq75bf3mqkjg
25 Jan 24
Entry into a Material Definitive Agreement
5:01pm
8-K
EX-99.1
eqxkelxz yl3bzvfxj8b
9 Aug 23
Jazz Pharmaceuticals Announces Second Quarter 2023 Financial Results and Raises 2023 Full Year Financial Guidance
4:07pm
8-K
EX-2.1
8tnjohvkbvc3dz9pta
5 Dec 22
Completion of Acquisition or Disposition of Assets
4:16pm
8-K
EX-99.1
k3icer1s bx54
19 Oct 22
Jazz Pharmaceuticals and Zymeworks Announce Exclusive License Agreement to Develop and Commercialize Zanidatamab, a HER2-Targeted Bispecific Antibody
6:59am
DEFA14A
a2sgnh2vfy jriaojmn7
7 Jul 22
Additional proxy soliciting materials
4:18pm